Increase/Decrease in Cash: The total change in cash for the company over the given period.
Aspen Pharmacare (APNHY) had Increase/Decrease in Cash of $-23.21M for the most recently reported fiscal quarter, ending 2024-12-31.
Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Balance Sheet Financials | |
$2.26B |
|
$1.15B |
|
$5.36B |
|
$7.62B |
|
$962.55M |
|
$1.72B |
|
$1.91B |
|
$2.87B |
|
$4.75B |
|
$711.78M |
|
$4.75B |
|
-- |
|
Cash Flow Statement Financials | |
$100.72M |
|
$-155.74M |
|
$53.51M |
|
$402.88M |
|
$379.66M |
|
Increase/Decrease in Cash |
$-23.21M |
-- |
|
$-89.34M |
|
-- |
|
Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |